CRITICAL Bio-Tech CJC-1295 5mg + Ipamorelin 5mg (Vial + Mixing Water Included)

**CJC-1295 + Ipamorelin** is a widely discussed peptide combination designed to enhance the body’s natural production of growth hormone (GH) through complementary mechanisms. CJC-1295 (typically in its non-DAC form, often referred to as Modified GRF 1-29) acts as a growth hormone–releasing hormone (GHRH) analog, stimulating the pituitary to initiate GH release. Ipamorelin, on the other hand, is a selective ghrelin receptor (GHS-R1a) agonist that amplifies GH secretion through a separate pathway. When used together, they create a synergistic effect by targeting both primary regulatory routes of GH release. Mechanistically, this combination mimics the body’s natural pulsatile rhythm of growth hormone secretion. CJC-1295 provides a baseline signal that primes the pituitary, while Ipamorelin triggers a more immediate GH pulse. Importantly, Ipamorelin is known for its selectivity, meaning it stimulates GH release with minimal impact on other hormones like cortisol or prolactin—an advantage compared to some older growth hormone–releasing peptides. The result is a more controlled and physiologically aligned increase in GH and downstream insulin-like growth factor 1 (IGF-1) levels. In research and performance-focused discussions, CJC-1295 + Ipamorelin is often associated with benefits such as improved recovery, enhanced sleep quality, support for lean muscle development, and potential fat metabolism improvements. Because it works by encouraging endogenous hormone production rather than supplying GH directly, it is generally positioned as a more balanced and regulatory-driven approach. The shorter half-life of non-DAC CJC-1295 also allows for better control over timing and dosing, aligning with natural GH pulses (often tied to sleep cycles). From a formulation and positioning standpoint, this stack is commonly viewed as a “foundational” growth hormone optimization protocol. It sits between entry-level peptides like Sermorelin and more aggressive downstream compounds like IGF-1 analogs. Its appeal lies in its balance—offering meaningful physiological effects while maintaining a degree of natural hormonal regulation, making it one of the most commonly referenced combinations in advanced peptide discussions.